Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04788966

Enrollment

Registered

2021-03-09

Start date

2018-11-29

Completion date

2020-01-20

Last updated

2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnoses Disease

Keywords

Translation tool, Anamnesis

Brief summary

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Interventions

DEVICEthe translation tool BabelDr

Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Satisfaction evaluation through a 4-point scale survey	During the consultation	Are patients' and doctors' satisfied with the use of BabelDr?
Efficacy evaluation through a 2-point scale survey	During the consultation	Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?
Technical features evaluation through a 4-point scale survey	During the consultation	Are the technical features appreciated by the doctors'?

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026